ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for

Spasovski, Goce*; Ortiz, Alberto; Vanholder, Raymond; El Nahas, Meguid
Proteomics Clinical Applications2011-6DOI: 10.1002/prca.201000150
19被引1阅读
引用收藏
分享

摘要

A growing number of patients are recognised to have chronic kidney disease (CKD). However, only a minority will progress to end-stage renal disease requiring dialysis or transplantation. Currently available diagnostic and staging tools frequently fail to identify those at higher risk of progression or death. Furthermore within specific disease entities there are shortcomings in the prediction of the need for therapeutic interventions or the response to different forms of therapy. Kidney and urine proteomic biomarkers are considered as promising diagnostic tools to predict CKD progression early in diabetic nephropathy, facilitating timely and selective intervention that may reduce the related health-care expenditures. However, independent groups have not validated these findings and the technique is not currently available for routine clinical care. Furthermore, there are gaps in our understanding of predictors of progression or need for therapy in non-diabetic CKD. Presumably, a combination of tissue and urine biomarkers will be more informative than individual markers. This review identifies clinical questions in need of an answer, summarises current information on proteomic biomarkers and CKD, and describes the European Kidney and Urine Proteomics initiative that has been launched to carry out a clinical study aimed at identifying urinary proteomic biomarkers distinguishing between fast and slow progressors among patients with biopsy-proven primary glomerulopathies.

学科与关键词

关键词
BiomarkersCardiovascular diseaseChronic kidney diseaseUrine
相关
加载中…
  • Proteomic biomarkers in kidney disease: issues in development and implementation
    Mischak, Harald; Delles, Christian; Vlahou, Antonia; Vanholder, Raymond*NATURE REVIEWS NEPHROLOGY, 2015, 11(4): 221-232.被引 95
  • Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma
    Manousos, Makridakis; Georgia, Kontostathi; Eleni, Petra; Rafael, Stroggilos; Vasiliki, Lygirou; Szymon, Filip; Flore, Duranton; Harald, Mischak; Angel, Argiles; Jerome, Zoidakis; Antonia, VlahouScientific Reports, 2020, 10(1): 4815.被引 2
  • URINARY EXOSOMAL microRNA AS POTENTIAL BIOMARKERS OF CHRONIC KIDNEY DISEASE
    Lv, Lin-Li; Cao, Yu-Han; Xu, Min; Liu, Bi-ChengNephrology Dialysis Transplantation, 2013, 28: 22-23.
查看全部 →

发表信息

论文状态
公开发表
期刊
Proteomics Clinical Applications
发表日期
2011-06
卷期
第 5 卷, 第 5-6 期
页码
233-240
DOI
10.1002/prca.201000150
语言
ENGLISH
成果收录
SCIE

作者

  • S

    Spasovski, Goce (通讯) (第一作者)

  • O

    Ortiz, Alberto

查看全部 4 位作者收起作者
  • V

    Vanholder, Raymond

  • E

    El Nahas, Meguid

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417